Skip to main content
SpineGuard logo

SpineGuard — Investor Relations & Filings

Ticker · ALSGD ISIN · FR0011464452 LEI · 969500Z4BRXQX6CSL565 PA Manufacturing
Filings indexed 466 across all filing types
Latest filing 2024-06-18 Capital/Financing Update
Country FR France
Listing PA ALSGD

About SpineGuard

https://www.spineguard.com/

SpineGuard is a medical technology company that develops and markets the proprietary Dynamic Surgical Guidance (DSG) technology. DSG is a radiation-free, real-time sensing platform designed to make spine surgery safer. The technology is embedded in the company's PediGuard family of smart drilling instruments, which assist surgeons in the accurate placement of skeletal implants, particularly pedicle screws. By differentiating tissue types at the instrument's tip, the devices provide audible and visual feedback to help anticipate potential breaches of the vertebral wall, thereby enhancing procedural safety and accuracy. SpineGuard's primary goal is to establish DSG as a standard of care for securing and streamlining skeletal implant placement.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Capital/Financing Update Classification · 99% confidence The document is a press release dated June 18, 2024, announcing the launch of a capital increase ('augmentation de capital') with preferential subscription rights ('maintien du droit préférentiel de souscription'). It details the subscription price (€0.19), parity (1 new share for 6 existing shares), subscription period (June 24 to July 3, 2024), and the total amount to be raised (€1.5M to €1.7M). This content directly relates to the company's fundraising and capital structure changes. Based on the definitions, the most appropriate code is 'CAP' (Capital/Financing Update). It is not a full annual report (10-K), an interim report (IR), or just a dividend notice (DIV). It is a specific announcement about a financing operation.
2024-06-18 French
Modalités de mise à disposition des documents préparatoires à l'AG
AGM Information Classification · 98% confidence The document is a press release announcing the date, time, and modalities for the company's 'Assemblée Générale Mixte' (Combined General Meeting). Key phrases include 'annonce la tenue de son Assemblée Générale Mixte' and details on voting procedures (VOTACCESS, correspondence). This directly relates to shareholder meetings and the materials associated with them. According to the definitions, 'AGM Information (Code: AGM-R)' covers 'Presentations and materials shared during the Annual General Meeting (AGM)'. Although this is an announcement of the meeting, it is the most specific category available for AGM-related communications, often preceding the actual AGM materials. Given the focus on the meeting logistics and voting, AGM-R is the best fit over a general Regulatory Filing (RNS). The document length (4783 chars) is substantial enough that it's not just a brief notification, but it is primarily focused on the meeting itself.
2024-04-29 French
Rapports financiers et d'audit annuels / Modalités de mise à disposition du rapport financier annuel
Report Publication Announcement Classification · 100% confidence The document is a short announcement (2673 characters) informing shareholders that the 2023 annual financial report has been filed with the AMF and is available for download on the company's website. It does not contain the actual financial statements or data, but rather serves as a notification of the report's publication. According to the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA). FY 2023
2024-04-23 French
Informations privilégiées / Communiqué sur comptes, résultats
Earnings Release Classification · 100% confidence The document explicitly announces "résultats annuels 2023" (annual results 2023) and includes detailed, audited financial tables covering revenue, gross margin, operating result, and net result for the full year 2023, alongside Q1 2024 revenue figures. This structure—a comprehensive review of the past fiscal year's performance with detailed financial statements—is characteristic of an Annual Report (10-K in the US context, or the equivalent comprehensive annual filing). Although it is presented as a press release announcing the results, the depth and inclusion of audited annual figures strongly suggest this document is the primary disclosure of the annual financial performance, aligning best with the '10-K' category, which covers the official yearly report covering company activity and full financial performance. It is not merely an Earnings Release (ER) as it contains full annual audited data, nor is it a Report Publication Announcement (RPA) because it contains the substance of the results, not just a notice that they are available. The presence of the CEO's commentary and detailed operational review further supports this classification. Q1 2024
2024-04-17 French
Inside Information / News release on accounts, results
Earnings Release Classification · 100% confidence The document explicitly announces 'SpineGuard announces its full-year 2023 financial results and its first quarter 2024 sales'. It contains detailed financial tables for the full year 2023 (audited figures) and Q1 2024 (unaudited figures), along with management commentary on performance and outlook. This structure is characteristic of a comprehensive financial results announcement, which typically combines elements of an Earnings Release (ER) and a Management Discussion & Analysis (MDA). However, since it provides the full audited/unaudited financial tables for the period, it goes beyond a simple 'key highlights only' ER. Given the depth of financial data and management discussion, it aligns best with a comprehensive report covering both past results and current period performance. Since the document covers both the full-year 2023 results (which would typically be in a 10-K or similar annual filing) and the Q1 2024 results (which would be in an Interim Report/IR), and it is presented as a press release announcing these results, the most fitting category that captures the release of detailed financial performance data for a period shorter than a year (Q1 2024) is the Interim Report (IR). If it were only the full-year results, 10-K might be considered, but the inclusion of Q1 2024 data makes IR more appropriate for the periodic reporting aspect, or ER if focusing on the release nature. Given the comprehensive nature including full tables and management discussion, it is a strong candidate for MDA or IR. Since it contains detailed financial statements for a period shorter than a year (Q1 2024), 'Interim Report' (IR) is a strong fit, although 'Management Reports' (MDA) also fits the detailed commentary. In many contexts, a press release detailing quarterly results with tables is classified as an Earnings Release (ER) or Interim Report (IR). Since it includes the full financial breakdown for Q1 2024, IR is chosen over the brief ER, and it is more specific than MDA which focuses on explanation rather than the primary result announcement. FY 2023
2024-04-17 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 85% confidence The document announces a significant step in the company's regulatory plan concerning its PediGuard® product line in China, specifically the submission of a dossier to the Chinese authorities ('NMPA') for renewed approval and extension to new models. This is a corporate update regarding regulatory progress and future product launches, not a full financial report (like 10-K or IR), an earnings release (ER), or a formal shareholder vote result (DVA). It details strategic business progress and regulatory milestones. Given the options, this type of announcement, which focuses on regulatory progress for product commercialization, fits best under a general 'Regulatory Filing' or 'Report Publication Announcement' if it were just announcing a report. Since it is a substantive announcement about a regulatory submission and strategic progress, and it doesn't fit perfectly into the other specific categories (like M&A, Financing, or Director Dealing), it is best classified as a general Regulatory Filing (RNS) or potentially a strategic update that might fall under a broader category if one existed. However, since it is a specific announcement about regulatory progress for market access, and not a standard financial report, RNS (Regulatory Filings - general regulatory announcements) is the most appropriate fallback, although it strongly relates to business operations and strategy.
2024-03-05 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.